59 filings
Page 3 of 3
8-K
tus8 6i0o1x
9 Sep 21
Departure of Directors or Certain Officers
7:00am
8-K
fy8g 58gtpcnhsfmeqx
17 Aug 21
Departure of Directors or Certain Officers
7:00am
8-K
flr7srtvnrbbe8y
12 Aug 21
Gemini Therapeutics Reports Second Quarter 2021 Financial Results
10:20am
8-K
1jnzwx
23 Jun 21
Gemini Therapeutics Announces Initial Data from its Ongoing Phase 2a Study of GEM103 in Patients with Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
8:52am
8-K
960mnixo
13 May 21
Gemini Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:30am
8-K
k4pxf0 fm5
7 May 21
Departure of Directors or Certain Officers
4:01pm
8-K
dvaitomv
14 Apr 21
Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer
5:21pm
8-K
re5cvh99 0x1rn
29 Mar 21
Gemini Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
4:46pm
8-K/A
pzrus
29 Mar 21
Financial Statements and Exhibits
4:05pm
8-K
yt71uo
23 Feb 21
Departure of Directors or Certain Officers
4:49pm
8-K
doyhm9o62 r5antqg5
11 Feb 21
Entry into a Material Definitive Agreement
4:30pm
8-K
7ye9mpztmoa9dtx4gi4
5 Feb 21
Regulation FD Disclosure
5:00pm
8-K
97h3wj6le6ujyyus
3 Feb 21
Submission of Matters to a Vote of Security Holders
3:19pm
8-K
e8h3c 1t4
28 Jan 21
Other Events
4:32pm
8-K
r0wt0s5ab6tmd 4ahj
19 Jan 21
FS Development Corp. Announces Effectiveness of Registration Statement for Proposed Business Combination with Gemini
4:39pm
8-K/A
yt8j39 t5r
20 Oct 20
Financial Statements and Exhibits
12:00am
8-K
hm1zs1tdvbgtbnkh2to
15 Oct 20
Entry into a Material Definitive Agreement
8:19am
8-K
h7n1s243
20 Aug 20
Report of Independent Registered Public Accounting Firm
4:28pm
8-K
4ovgy58u2f85u
14 Aug 20
FS Development Corp., Sponsored by Foresite Capital, Announces Pricing of Upsized $105 Million Initial Public Offering
5:27pm